Steatotic liver disease and diabetes: prolific nomenclature, insufficient data, and poor treatment options

被引：0
|
作者：
不详
机构：
来源：
LANCET REGIONAL HEALTH-AMERICAS | 2024年 / 36卷
关键词：
D O I：
10.1016/j.lana.2024.100865
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Living donor liver transplantation for metabolic dysfunction and alcohol associated/related liver disease versus alcohol associated liver disease:Implications of applying the new steatotic liver disease nomenclature
    Shetty, N.
    Dhampalwar, S.
    Singh, K. A.
    Saraf, N.
    Choudhary, N. S.
    Bhangui, P.
    Rastogi, A.
    Gupta, A.
    Yadav, K.
    Valappil, F. K.
    Chaud-Hary, S.
    Bansal, R.
    Soin, A. S.
    LIVER TRANSPLANTATION, 2024, 30 : 50 - 50
  • [42] Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?
    Petroni, Maria Letizia
    Perazza, Federica
    Marchesini, Giulio
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (09) : 1442 - 1451
  • [43] Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease
    Nendouvhada, Livhuwani P.
    Sibuyi, Nicole R. S.
    Fadaka, Adewale O.
    Meyer, Samantha
    Madiehe, Abram M.
    Meyer, Mervin
    Gabuza, Kwazikwakhe B.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [44] Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
    Tziomalos, Konstantinos
    Athyros, Vassilios G.
    Karagiannis, Asterios
    CURRENT VASCULAR PHARMACOLOGY, 2012, 10 (02) : 162 - 172
  • [45] Hepatic mitochondrial reductive stress in the pathogenesis and treatment of steatotic liver disease
    Jokinen, Mari J.
    Luukkonen, Panu K.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2024, 45 (04) : 319 - 334
  • [46] NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature?
    Gastaldelli, Amalia
    Newsome, Philip N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [47] Shedding lights on diagnostic challenges in Wilson's disease: The positive impact of introducing steatotic liver disease new nomenclature umbrella
    Hassan, Marwa Khalaf
    Alswat, Khalid
    El-Kassas, Mohamed
    LIVER INTERNATIONAL, 2024, 44 (05) : 1267 - 1268
  • [48] APPLYING THE METABOLIC DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE ( MASLD) NOMENCLATURE WITH NATURAL LANGUAGE PROCESSING IN A NATIONAL COHORT
    John, Binu
    Bastaich, Dustin
    Mezzacappa, Catherine
    Ferreira, Raphaella
    Hentschel, Austen
    Samos, Andres
    Mahmud, Nadim
    Taddei, Tamar
    Kaplan, David
    Serper, Marina
    Dahman, Bassam
    HEPATOLOGY, 2024, 80 : S1566 - S1567
  • [49] The new international nomenclature for steatotic liver disease: One step forward towards enhanced awareness for healthier life
    van Erpecum, Karel J.
    van Kleef, Laurens A.
    Beuers, Ulrich
    de Knegt, Robert J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 117 : 1 - 2
  • [50] Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practice
    Brennan, Paul N.
    Tavabie, Oliver
    Li, Wenhao
    Marjot, Thomas
    Corless, Lynsey
    Fallowfield, Jonathan A.
    Jarvis, Helen
    Mansour, Dina
    Mcpherson, Stuart
    Rosenberg, William
    Rockell, Karen
    Tomlinson, Jeremy
    Yeoman, Andrew
    Tsochatzis, Emmanuel A.
    Dillon, John F.
    Alazawi, William
    Abeysekera, Kushala W. M.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2024, 9 (06): : 577 - 582
12345